The use of Cortexin as an additional therapy in patients with depressive disorder is effective and safe. Combined antidepressant therapy with Cortexin is superior to antidepressant monotherapy in terms of response rate and health-related quality of life. A more favorable safety profile was also demonstrated for the combination of antidepressants and Cortexin.
ED Schastnyy (Thu,) studied this question.